| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/02/2011 | US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture |
| 06/02/2011 | US20110129527 Rab3b for the treatment and prevention of parkinson's disease |
| 06/02/2011 | US20110129517 Tablettable chewing gums |
| 06/02/2011 | US20110129515 Devices and Methods for Nerve Regeneration |
| 06/02/2011 | US20110129488 Immunotherapy compositions for the treatment and prevention of amyloidosis |
| 06/02/2011 | US20110129477 NOGO Receptor Homologs |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129462 Intranasal administration of active agents to the central nervous system |
| 06/02/2011 | US20110129450 Method of promoting neurogenesis by modulating secretase activities |
| 06/02/2011 | US20110129447 Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy |
| 06/02/2011 | US20110129422 Viscous Terpolymers as Drug Delivery Platform |
| 06/01/2011 | EP2327713A1 Metal-binding compounds and uses therefor |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2327703A1 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment |
| 06/01/2011 | EP2327698A1 Process for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate |
| 06/01/2011 | EP2327413A1 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 06/01/2011 | EP2327412A1 Treatment of nerve injuries |
| 06/01/2011 | EP2327402A2 Composition containing 4-o-methylhonokiol for treating or preventing amyloid- related diseases |
| 06/01/2011 | EP2326655A1 Aminophosphinic derivatives that can be used in the treatment of pain |
| 06/01/2011 | EP2326651A1 Buprenorphine analogs |
| 06/01/2011 | EP2326645A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 06/01/2011 | EP2326643A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 06/01/2011 | EP2326642A2 Salt of, and processes for the preparation of, 1-isopropyl-4-{[4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine |
| 06/01/2011 | EP2326639A1 Substituted pyridines, and use thereof as gsk3 inhibitors |
| 06/01/2011 | EP2326635A1 Novel substituted sulfamide derivatives |
| 06/01/2011 | EP2326632A2 Novel choline cocrystal of epalrestat |
| 06/01/2011 | EP2326625A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 06/01/2011 | EP2326339A2 Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
| 06/01/2011 | EP2326333A1 Agent for promoting neuronal differentiation and method therefor |
| 06/01/2011 | EP2326328A1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity |
| 06/01/2011 | EP2326325A1 Compounds for the treatment of peripheral neuropathies |
| 06/01/2011 | EP2326323A1 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 06/01/2011 | EP2326311A1 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
| 06/01/2011 | EP2326176A1 Non-amidic linkers with branched termini as cgrp receptor antagonists |
| 06/01/2011 | EP2326175A2 Allosteric enhancers of the a1 adenosine receptor |
| 06/01/2011 | EP2245006B1 Sulfonamides as orexin antagonists |
| 06/01/2011 | EP1930020B1 Chinese medicinal compositions for treating headache, formulations and processes for preparation thereof |
| 06/01/2011 | EP1838716B1 Olanzapine pamoate dihydrate |
| 06/01/2011 | EP1622914B1 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 06/01/2011 | EP1584925B1 Novel screening method |
| 06/01/2011 | EP1354946B1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 06/01/2011 | EP1169314B2 Process for the manufacture of salts of citalopram |
| 06/01/2011 | DE10203923B4 Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung A method for increasing the water solubility of lipophilic active ingredients, preparation of highly concentrated aqueous compositions of these active ingredients such products and their use |
| 06/01/2011 | CN1953977B Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof |
| 06/01/2011 | CN102083849A Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 06/01/2011 | CN102083841A Novel class of spiro piperidines for the treatment of neurodegenerative diseases |
| 06/01/2011 | CN102083832A Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 Tachikynin receptor antagonists |
| 06/01/2011 | CN102083830A Pyrido [3, 4-b] indoles and methods of use |
| 06/01/2011 | CN102083828A Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors |
| 06/01/2011 | CN102083827A Thiazolidine compounds as orexin receptor antagonists |
| 06/01/2011 | CN102083820A Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 06/01/2011 | CN102083812A Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia |
| 06/01/2011 | CN102083810A Activator for peroxisome proliferator-activated receptor |
| 06/01/2011 | CN102083805A 4,5-dihydro-oxazol-2-yl derivatives |
| 06/01/2011 | CN102083804A 5-phenyl-isoxazole-3-carboxamides modulating HSP90 with antitumoral activities |
| 06/01/2011 | CN102083799A Benzimidazole derivatives used as FXR agonists |
| 06/01/2011 | CN102083797A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 06/01/2011 | CN102083794A Urea compounds as gamma secretase modulators |
| 06/01/2011 | CN102083790A Spiro(5.5)undecane derivatives |
| 06/01/2011 | CN102083787A Vinyl substituted fatty acids |
| 06/01/2011 | CN102083456A Neurodegenerative disorders |
| 06/01/2011 | CN102083453A Anxiolytic composition containing [alpha]s1-casein-derived peptides |
| 06/01/2011 | CN102083446A Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use |
| 06/01/2011 | CN102083442A Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 |
| 06/01/2011 | CN102083437A Treatment of herpes virus related diseases |
| 06/01/2011 | CN102083431A Use of cyclolignans for the treatment of a hyperactive immune system |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102080086A Human miR-133a antisense nucleic acid and application thereof |
| 06/01/2011 | CN102080085A Human miR-193b antisense nucleotide and application thereof |
| 06/01/2011 | CN102080084A Human miR-125a-5p antisense nucleotide and application thereof |
| 06/01/2011 | CN102080083A Human miR-149 antisense nucleotide and application thereof |
| 06/01/2011 | CN102080082A Human miR-129* antisensenucleic acid and applications thereof |
| 06/01/2011 | CN102080018A Tree peony essential oil |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102079763A Dioxabicyclo-octane compound, preparation method and application thereof |
| 06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
| 06/01/2011 | CN102079735A Terphenyl compound and preparation method thereof and application of compound as acetylcholinesterase inhibitor |
| 06/01/2011 | CN102079717A Arginine salt compound of dibasic ester acids and preparation method and medicinal application thereof |
| 06/01/2011 | CN102079715A Lysine salt compound of binary ester acid, preparation method and medicinal application |
| 06/01/2011 | CN102079699A New crystal form for sodium valproate and preparation method and usage thereof |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078591A Series of medicines for mental negative by using four-step treatment method |
| 06/01/2011 | CN102078576A Chinese medicine powder for treating epilepsy |
| 06/01/2011 | CN102078566A Medicine for treating schizophrenia |
| 06/01/2011 | CN102078559A Chinese medicinal composition with functions of tonifying kidney and strengthening brain |
| 06/01/2011 | CN102078555A Traditional Chinese medicine for treating migraine |
| 06/01/2011 | CN102078540A Series medicines for psychosis negative four-step treatment |
| 06/01/2011 | CN102078539A Medicines based on negative classification and four-step therapy of psychosis |
| 06/01/2011 | CN102078528A Medicinal composition for treating migraine and preparation method thereof |
| 06/01/2011 | CN102078523A Traditional Chinese medicine decoction for treating spasm and convulsion caused by fulgurating high fever |
| 06/01/2011 | CN102078520A Chinese medicinal preparation for treating nervous headache and preparation method thereof |
| 06/01/2011 | CN102078518A Traditional Chinese medicine composition for treating trigeminal neuralgia |
| 06/01/2011 | CN102078514A Bupleurum root and asarum herb oral liquid as Chinese herbal medicine cerebral concussion therapeutic agent |
| 06/01/2011 | CN102078480A Nano element traditional Chinese medicine negative ion far infrared electromagnetic wave-resistant life prolonging medicinal liquor |
| 06/01/2011 | CN102078479A Saffron crocus dissolved medicine and preparation method thereof |
| 06/01/2011 | CN102078474A Nano-dispersible tablet for four-season common cold and preparation method thereof |
| 06/01/2011 | CN102078460A Traditional Chinese medicine for preventing and treating Alzheimer disease and preparation method thereof |
| 06/01/2011 | CN102078438A Traditional Chinese medicine composition for treating neurasthenia |
| 06/01/2011 | CN102078433A Medicine for treating insomnia and preparation method thereof |